Pfizer (PFE) Tops Q2 EPS by 33c, Reaffirms FY22 Comirnaty and Paxlovid Sales Guidance
Go back to Pfizer (PFE) Tops Q2 EPS by 33c, Reaffirms FY22 Comirnaty and Paxlovid Sales Guidance| Pfizer Inc. (NYSE: PFE) | Delayed: 24.72 -0.36 (1.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.08 | 52 Week High | $37.39 | |||
| Open | $24.99 | 52 Week Low | $28.25 | |||
| Day High | $25.24 | P/E | 14.98 | |||
| Day Low | $24.69 | EPS | $1.65 | |||
| Volume | 81,994,445 | |||||
